Net Cash Provided by (Used in) Financing Activities of BIOGEN INC. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOGEN INC. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • BIOGEN INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $23,000,000, a 95% increase year-over-year.
  • BIOGEN INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $301,900,000, a 56% increase from 2024.
  • BIOGEN INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $683,500,000, a 558% decline from 2023.
  • BIOGEN INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $149,300,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BIOGEN INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $301,900,000 +$381,600,000 +56% 01 Jan 2025 31 Dec 2025 10-K 06 Feb 2026 2025 FY
2024 $683,500,000 -$832,800,000 -558% 01 Jan 2024 31 Dec 2024 10-K 06 Feb 2026 2025 FY
2023 $149,300,000 +$1,896,600,000 01 Jan 2023 31 Dec 2023 10-K 06 Feb 2026 2025 FY
2022 $1,747,300,000 +$338,900,000 +16% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025 2024 FY
2021 $2,086,200,000 +$3,186,500,000 +60% 01 Jan 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
2020 $5,272,700,000 +$587,700,000 +10% 01 Jan 2020 31 Dec 2020 10-K 15 Feb 2023 2022 FY
2019 $5,860,400,000 -$1,388,400,000 -31% 01 Jan 2019 31 Dec 2019 10-K 03 Feb 2022 2021 FY
2018 $4,472,000,000 -$2,092,000,000 -88% 01 Jan 2018 31 Dec 2018 10-K 03 Feb 2021 2020 FY
2017 $2,380,000,000 -$1,327,400,000 -126% 01 Jan 2017 31 Dec 2017 10-K 06 Feb 2020 2019 FY
2016 $1,052,600,000 -$1,835,700,000 -234% 01 Jan 2016 31 Dec 2016 10-K 06 Feb 2019 2018 FY
2015 $783,100,000 +$1,539,000,000 01 Jan 2015 31 Dec 2015 10-K 01 Feb 2018 2017 FY
2014 $755,900,000 -$39,400,000 -5.5% 01 Jan 2014 31 Dec 2014 10-K 02 Feb 2017 2016 FY
2013 $716,500,000 +$160,978,000 +18% 01 Jan 2013 31 Dec 2013 10-K 03 Feb 2016 2015 FY
2012 $877,478,000 -$557,616,000 -174% 01 Jan 2012 31 Dec 2012 10-K 04 Feb 2015 2014 FY
2011 $319,862,000 +$1,465,057,000 +82% 01 Jan 2011 31 Dec 2011 10-K 06 Feb 2014 2013 FY
2010 $1,784,919,000 01 Jan 2010 31 Dec 2010 10-K 05 Feb 2013 2012 FY

BIOGEN INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $23,000,000 +$416,600,000 +95% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $439,600,000 -$396,200,000 -913% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $43,400,000 -$26,900,000 -163% 01 Jan 2023 31 Mar 2023 10-Q 24 Apr 2024 2024 Q1
Q1 2022 $16,500,000 +$768,500,000 +98% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023 2023 Q1
Q1 2021 $785,000,000 +$1,460,300,000 +65% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $2,245,300,000 -$1,566,000,000 -231% 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021 2021 Q1
Q1 2019 $679,300,000 -$410,700,000 -153% 01 Jan 2019 31 Mar 2019 10-Q 23 Apr 2020 2020 Q1
Q1 2018 $268,600,000 +$632,800,000 +70% 01 Jan 2018 31 Mar 2018 10-Q 24 Apr 2019 2019 Q1
Q1 2017 $901,400,000 -$896,400,000 -17928% 01 Jan 2017 31 Mar 2017 10-Q 24 Apr 2018 2018 Q1
Q1 2016 $5,000,000 -$85,800,000 -106% 01 Jan 2016 31 Mar 2016 10-Q 25 Apr 2017 2017 Q1
Q1 2015 $80,800,000 -$34,075,000 -30% 01 Jan 2015 31 Mar 2015 10-Q 21 Apr 2016 2016 Q1
Q1 2014 $114,875,000 +$353,299,000 01 Jan 2014 31 Mar 2014 10-Q 24 Apr 2015 2015 Q1
Q1 2013 $238,424,000 +$177,840,000 +43% 01 Jan 2013 31 Mar 2013 10-Q 23 Apr 2014 2014 Q1
Q1 2012 $416,264,000 -$316,432,000 -317% 01 Jan 2012 31 Mar 2012 10-Q 25 Apr 2013 2013 Q1
Q1 2011 $99,832,000 +$423,628,000 +81% 01 Jan 2011 31 Mar 2011 10-Q 01 May 2012 2012 Q1
Q1 2010 $523,460,000 01 Jan 2010 31 Mar 2010 10-Q 21 Apr 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.